Klinger H, Stevens L M, Roberts E F. "Method for the Synthesis of 1-(5-Ethylthiophen-2-yl)-2-(4-nitro-1h-imidazol-1-yl)ethan-1-one" [P]. US Patent, US 10300704 B2, 2018-04-25.
Yamamoto T, Williams B T, Kumar R. "A Process for Preparing High-Purity 1-(5-Ethylthiophen-2-yl)-2-(4-nitro-1h-imidazol-1-yl)ethan-1-one" [P]. US Patent, US 11089858 B2, 2022-10-05.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2023, 2225, (7), 7019-7040.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2016, 837, 9591-9615.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 1-(5-Ethylthiophen-2-yl)-2-(4-nitro-1h-imidazol-1-yl)ethan-1-one Using HRMS and NMR". Biomed. Chromatogr., 2013, 2446, (10), 7333-7360.